Edwards Lifesciences Balance Sheet Health
Financial Health criteria checks 6/6
Edwards Lifesciences has a total shareholder equity of $6.7B and total debt of $597.0M, which brings its debt-to-equity ratio to 8.9%. Its total assets and total liabilities are $9.4B and $2.6B respectively. Edwards Lifesciences's EBIT is $1.7B making its interest coverage ratio -34.9. It has cash and short-term investments of $1.6B.
Key information
8.9%
Debt to equity ratio
US$597.00m
Debt
| Interest coverage ratio | -34.9x |
| Cash | US$1.64b |
| Equity | US$6.72b |
| Total liabilities | US$2.64b |
| Total assets | US$9.36b |
Recent financial health updates
Here's Why Edwards Lifesciences (NYSE:EW) Can Manage Its Debt Responsibly
Jan 28
Does Edwards Lifesciences (NYSE:EW) Have A Healthy Balance Sheet?
Oct 23Does Edwards Lifesciences (NYSE:EW) Have A Healthy Balance Sheet?
Jul 16Edwards Lifesciences (NYSE:EW) Has A Rock Solid Balance Sheet
Apr 03Is Edwards Lifesciences (NYSE:EW) A Risky Investment?
Dec 28Recent updates
Calculating The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)
Apr 15Edwards Lifesciences Corporation's (NYSE:EW) Popularity With Investors Is Clear
Apr 01Edwards Lifesciences' (NYSE:EW) Soft Earnings Don't Show The Whole Picture
Feb 21Edwards Lifesciences: EVOQUE FDA Approval; Critical Care Spin-Off (Rating Maintained)
Feb 14Edwards Lifesciences Corporation (NYSE:EW) Released Earnings Last Week And Analysts Lifted Their Price Target To US$90.47
Feb 08Here's Why Edwards Lifesciences (NYSE:EW) Can Manage Its Debt Responsibly
Jan 28The Returns At Edwards Lifesciences (NYSE:EW) Aren't Growing
Jan 14Edwards Lifesciences: Undervalued With A Substantial Upside Potential
Jan 09Edwards Lifesciences Corporation's (NYSE:EW) Share Price Not Quite Adding Up
Dec 31Calculating The Fair Value Of Edwards Lifesciences Corporation (NYSE:EW)
Dec 17Edwards Lifesciences: Sector Derating A Bigger Threat Than Competition Or Slowing Markets
Oct 26Does Edwards Lifesciences (NYSE:EW) Have A Healthy Balance Sheet?
Oct 23Is Now The Time To Look At Buying Edwards Lifesciences Corporation (NYSE:EW)?
Oct 09Edwards Lifesciences (NYSE:EW) Is Reinvesting To Multiply In Value
Sep 26A Look At The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)
Sep 11Edwards Lifesciences: Rising Dominance In Structural Heart Disease
Aug 21Does Edwards Lifesciences (NYSE:EW) Have A Healthy Balance Sheet?
Jul 16Is It Too Late To Consider Buying Edwards Lifesciences Corporation (NYSE:EW)?
Jun 30Edwards Lifesciences (NYSE:EW) Is Reinvesting To Multiply In Value
Jun 15Edwards Lifesciences: Valuation Premium Earned, But Shares Are Not Cheap, Technicals Mixed
Jun 12Are Edwards Lifesciences Corporation (NYSE:EW) Investors Paying Above The Intrinsic Value?
May 31Edwards Lifesciences (NYSE:EW) Has A Rock Solid Balance Sheet
Apr 03What Is Edwards Lifesciences Corporation's (NYSE:EW) Share Price Doing?
Mar 22Investors Shouldn't Overlook The Favourable Returns On Capital At Edwards Lifesciences (NYSE:EW)
Mar 10Calculating The Fair Value Of Edwards Lifesciences Corporation (NYSE:EW)
Feb 26Edwards Lifesciences downgraded to market perform at Raymond James on growth challenges
Feb 06Edwards Lifesciences slips as Piper downgrades on challenging setup
Jan 30Edwards Lifesciences: Short-Term Growth Worries Have Created An Opportunity
Jan 18Edwards Lifesciences: Catalysts For 2023 And Beyond
Dec 30Is Edwards Lifesciences (NYSE:EW) A Risky Investment?
Dec 28Is It Too Late To Consider Buying Edwards Lifesciences Corporation (NYSE:EW)?
Dec 16Edwards Lifesciences CEO Michael Mussallem to retire
Dec 08Edwards Lifesciences (NYSE:EW) Knows How To Allocate Capital
Dec 04Estimating The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)
Nov 22Financial Position Analysis
Short Term Liabilities: EW's short term assets ($4.0B) exceed its short term liabilities ($1.2B).
Long Term Liabilities: EW's short term assets ($4.0B) exceed its long term liabilities ($1.4B).
Debt to Equity History and Analysis
Debt Level: EW has more cash than its total debt.
Reducing Debt: EW's debt to equity ratio has reduced from 18.9% to 8.9% over the past 5 years.
Debt Coverage: EW's debt is well covered by operating cash flow (150.1%).
Interest Coverage: EW earns more interest than it pays, so coverage of interest payments is not a concern.